LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

PerkinElmer Transforms into New Life Sciences & Diagnostics Company with Completion of Business Divestitures

By LabMedica International staff writers
Posted on 15 Mar 2023
Print article
Image: PerkinElmer has completed the divestiture of its applied, food and enterprise services businesses (Photo courtesy of PerkinElmer)
Image: PerkinElmer has completed the divestiture of its applied, food and enterprise services businesses (Photo courtesy of PerkinElmer)

PerkinElmer, Inc. (Waltham, MA; USA) has successfully completed the previously announced divestiture of its Applied, Food, and Enterprise Services businesses. The resulting new, high-growth Life Sciences and Diagnostics business, focused on developing and delivering novel scientific breakthroughs that are expected to have a significant impact on improving global health, will share the PerkinElmer name with the Applied, Food and Enterprise Services businesses until a new name, brand, and ticker symbol is introduced in Q2 2023 pending shareholder approval.

The two main areas of focus for the company are Life Sciences and Diagnostics, both of which have the potential to drive scientific innovation and positively impact human health. The Life Sciences division is dedicated to providing support for pharmaceutical and academic research, starting from the earliest stages of discovery and continuing all the way to entering the clinic. Meanwhile, the Diagnostics division strives to continuously develop new assays, systems, and workflows for the diagnosis of diseases along the entire continuum of care, spanning all laboratory settings.

“Today marks the culmination of the hard work and dedication from PerkinElmer teams around the world to ensure that both new companies are in a position to succeed on day one,” said Prahlad Singh, president, and chief executive officer of the PerkinElmer Life Sciences and Diagnostics company. “As we look ahead, our new Life Sciences and Diagnostics organization has an immense opportunity to continue to lead with science to redefine human health. I’m looking forward to sharing our new name and brand in the near future.”

Related Links:
PerkinElmer, Inc.

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Troponin I Test
Quidel Triage Troponin I Test
New
Immunofluorescence Analyzer
MPQuanti

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.